EZYNHA
Live / Registered — Registered (as of 05 Aug 2025)
What this means for you
Registered since 05 Aug 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90489374
- Registration number
- 7877326
- Mark type
- Stylized text
- Filed
- 26 Jan 2021
- Published for opposition
- 07 Dec 2021
- Registered
- 05 Aug 2025
- Attorney of record
- Boris Umansky
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leukemia, metastasis, musculoskeletal disorders, muscular dystrophy, pseudoxanthoma, dermatological disorders, allergy, cardiovascular diseases, kidney diseases [; Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leukemia, metastasis, musculoskeletal disorders, muscular dystrophy, pseudoxanthoma, dermatological disorders, allergy, cardiovascular diseases, kidney diseases]
Owner
- DAIICHI SANKYO COMPANY, LIMITED, Chuo-ku, Tokyo, JP
- DAIICHI SANKYO COMPANY, LIMITED, Chuo-ku, Tokyo, JP
- DAIICHI SANKYO COMPANY, LIMITED, Chuo-ku, Tokyo, JP
Prosecution history
- 24 Mar 2026 — NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
- 03 Mar 2026 — CORRECTION UNDER SECTION 7 - PROCESSED
- 15 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 15 Feb 2026 — POST REGISTRATION ACTION MAILED - SEC. 7
- 09 Feb 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 Nov 2025 — TEAS SECTION 7 REQUEST RECEIVED
- 05 Aug 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Aug 2025 — REGISTERED-PRINCIPAL REGISTER
- 15 Jul 2025 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 24 Jan 2025 — NOTICE OF ALLOWANCE CANCELLED
- 15 Jul 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Jan 2025 — TEAS DELETE 1(B) BASIS RECEIVED
- 01 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Jul 2024 — SOU EXTENSION 5 GRANTED
- 01 Jul 2024 — SOU EXTENSION 5 FILED